In this prospective cohort study, we investigated the relationship between SLC22A1 rs628031, SLC22A2 rs316019, SLC47A1 rs2289669, and SLC47A2 rs12943590, and metformin efficacy in T2DM patients. The gene discussed is SLC47A1; the disease is type 2 diabetes mellitus.